Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

Returns vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Sanofi India has accepted the resignation of its managing director (MD), Rajaram Narayanan, effective close of business hours on 10 April 2022.

Sanofi India MD Rajaram Narayanan steps down to pursue other opportunities

“In these roles, he has led the strategic reorientation of the organisation, sharpening its focus on core areas, developing new business models, building future talent and driving digital transformation across all areas of the business,” the company said.

Sanofi India’s managing director Rajaram Narayanan steps down

The company’s board has accepted the resignation of Rajaram Narayanan, effective from the close of business hours on April 10, 2022, Sanofi India said in a statement.

Sanofi India MD Rajaram Narayanan Resigns

Drug firm Sanofi India on Thursday said its Managing Director Rajaram Narayanan has put in his papers

Sanofi India Managing Director Rajaram Narayanan resigns

He has over 21 years of work experience across companies like Sanofi, GSK Pharmaceuticals, Medtronic and Dr. Lal Pathlabs.

Fortis Malar Hospitals appoints Chandrasekar Ramasamy as Whole Time Director and KMP

Alembic has settled the case with Sanofi-Aventis and will launch its generic as per the terms of the settlement

Alembic Pharma: More product approvals for U.S. launches suggest worst is behind

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Multaq Tablets, 400 mg, of Sanofi-Aventis U.S. LLC (Sanofi-Aventis).

Alembic Pharma receives US FDA tentative approval for dronedarone tablets

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Multaq Tablets, 400 mg, of Sanofi-Aventis U.S. LLC (SanofiAventis). Dronedarone is indicated to reduce, the risk of hospitalization for atria)

Alembic Pharmaceuticals receives USFDA tentative approval for Dronedarone Tablets

Sanofi Forms Potential $5.2 Billion AI Deal With Exscientia

Biocon Biologics said that the US Court of Appeals for the Federal Circuit upheld the US Patent and Trademark Appeal Board’s decisions for unpatentability of five device patents for Sanofi’s Lantus SoloSTAR and a district court decision on a patent.

Biocon subsiary, Biocon Biologics’ partner Viatris wins favourable order from U.S. court

The U.S. Court of Appeals for the Federal Circuit (USCAFC) has upheld the U.S. Patent and Trademark Appeal Board’s decisions for unpatentability of five device patents for Sanofi’s Lantus SoloSTAR.

Biocon stock gains over 1% as Biocon Biologics partner Viatris wins US court decisions on Sanofi appeals for Lantus Device Patents

Sanofi India Limited is engaged in the manufacture and sale of pharmaceutical products.

Sanofi India Ltd

Sanofi India Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Sanofi India MD Rajaram Narayanan steps down to pursue other opportunities

Sanofi India’s managing director Rajaram Narayanan steps down

Sanofi India MD Rajaram Narayanan Resigns

Sanofi India Managing Director Rajaram Narayanan resigns

Fortis Malar Hospitals appoints Chandrasekar Ramasamy as Whole Time Director and KMP

Alembic Pharma: More product approvals for U.S. launches suggest worst is behind

Alembic Pharma receives US FDA tentative approval for dronedarone tablets

Sanofi India Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Sanofi India MD Rajaram Narayanan steps down to pursue other opportunities

Sanofi India’s managing director Rajaram Narayanan steps down

Sanofi India MD Rajaram Narayanan Resigns

Sanofi India Managing Director Rajaram Narayanan resigns

Fortis Malar Hospitals appoints Chandrasekar Ramasamy as Whole Time Director and KMP

Alembic Pharma: More product approvals for U.S. launches suggest worst is behind

Alembic Pharma receives US FDA tentative approval for dronedarone tablets

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock